Additional file 8. Figure S5: Prognostic values of ctDNA detection based on clonal and subclonal mutations. A). The recurrence-free survival analysis of patients stratified by ctDNA detection based on only clonal mutation profiles. B). The recurrence-free survival analysis of patients stratified by ctDNA detection based on all clonal and subclonal mutations
Figure S1. The correlations of TMB value between panel sequencing and WES in published databases. Fi...
Circulating tumour DNA (ctDNA) can be used to detect and profile residual tumour cells persisting af...
Additional file 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) check...
Additional file 10. Figure S7: Prognostic value of presurgical ctDNA detection. A). The recurrence-f...
Additional file 6. Figure S3: Prognostic values of postsurgical ctDNA detection at 3 months and 6 mo...
Additional file 7. Figure S4: ctDNA statuses and disease-related events of patients during follow-up...
Additional file 9. Figure S6: ctDNA testing, LDCT scans, and disease-related events of patients duri...
Additional file 5. Figure S2: Mutational profile of plasma samples. Gene mutations detected in tissu...
Additional file 4. Figure S1: Availability of plasma samples. The availability of plasma samples for...
Additional file 2: Supplementary Table 1. cfDNA Samples Included in 23This Analysisa. Abbreviations:...
Chuangzhou Rao,1 Liangqin Nie,1 Xiaobo Miao,1 Yunbao Xu,1 Bing Li,2 Tengfei Zhang2 1Radiotherapy &a...
Graphical test of the Weibull assumption. Plot of log(-log(Survival)) vs log(time). When the result ...
Figure S1. UC-Seq significantly improve the sensitivity of mutation detection in ctDNA. (A) Sensitiv...
Estimated Survival Curves adjusted by sex and age using Cox regression for CTC and KRAS Mutant model...
Additional file 3: Table S1. Baseline clinicopathologic characteristics of the 36 patients in the DY...
Figure S1. The correlations of TMB value between panel sequencing and WES in published databases. Fi...
Circulating tumour DNA (ctDNA) can be used to detect and profile residual tumour cells persisting af...
Additional file 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) check...
Additional file 10. Figure S7: Prognostic value of presurgical ctDNA detection. A). The recurrence-f...
Additional file 6. Figure S3: Prognostic values of postsurgical ctDNA detection at 3 months and 6 mo...
Additional file 7. Figure S4: ctDNA statuses and disease-related events of patients during follow-up...
Additional file 9. Figure S6: ctDNA testing, LDCT scans, and disease-related events of patients duri...
Additional file 5. Figure S2: Mutational profile of plasma samples. Gene mutations detected in tissu...
Additional file 4. Figure S1: Availability of plasma samples. The availability of plasma samples for...
Additional file 2: Supplementary Table 1. cfDNA Samples Included in 23This Analysisa. Abbreviations:...
Chuangzhou Rao,1 Liangqin Nie,1 Xiaobo Miao,1 Yunbao Xu,1 Bing Li,2 Tengfei Zhang2 1Radiotherapy &a...
Graphical test of the Weibull assumption. Plot of log(-log(Survival)) vs log(time). When the result ...
Figure S1. UC-Seq significantly improve the sensitivity of mutation detection in ctDNA. (A) Sensitiv...
Estimated Survival Curves adjusted by sex and age using Cox regression for CTC and KRAS Mutant model...
Additional file 3: Table S1. Baseline clinicopathologic characteristics of the 36 patients in the DY...
Figure S1. The correlations of TMB value between panel sequencing and WES in published databases. Fi...
Circulating tumour DNA (ctDNA) can be used to detect and profile residual tumour cells persisting af...
Additional file 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) check...